Obagi Medical Products, Inc. (OMPI) Tops Q3 EPS by 9c; Issues Mixed Outlook
Tweet Send to a Friend
Obagi Medical Products, Inc. (NASDAQ: OMPI) reported Q3 EPS of $0.22, $0.09 better than the analyst estimate of $0.13. Revenue ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
